Literature DB >> 2976753

[Epicutaneous testing with a standard series. Results in 12,026 patients].

F Enders1, B Przybilla, J Ring, G Burg, O Braun-Falco.   

Abstract

From 1977 to 1983, 12,026 patients were given patch tests with a standard series of substances. A total of 4,494 (37.4%) had positive patch-test reactions to one or more allergens; the average number of positive reactions was 1.85. The most frequent reactions were due to nickel sulphate (positive reactions in 9.2% of those tested), fragrance mix (8.9%), balsam of Peru (6.3%), cobalt chloride (4.7%), potassium dichromate (4.3%) and wool alcohols (4.3%). Women showed significantly more positive reactions than men to nickel sulphate, cobalt chloride, wool alcohols, and parabens and significantly fewer positive reactions than men to potassium dichromate, PPD mix, and epoxy resin. Younger patients showed significant more positive reactions to nickel sulphate and cobalt chloride; middle-aged patients reacted more to potassium dichromate, paraphenylendiamine, formaldehyde and thiuram mix; elderly patients reacted to balsam of Peru, wool alcohols, caine mix, neomycin sulfate, benzocaine, colophony, clioquinol, mafenide, parabens, and gentamycin sulfate.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2976753

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  3 in total

1.  [Do sulfonamides still retain a place in dermatological therapy?].

Authors:  A Schnuch
Journal:  Hautarzt       Date:  2002-03       Impact factor: 0.751

2.  [Contact allergens in the standard patch test series from 1980-2004 at the University Clinic Aachen].

Authors:  D Hoeller Obrigkeit; N Vens; H F Merk; C M Schroeder
Journal:  Hautarzt       Date:  2005-12       Impact factor: 0.751

3.  Screening for skin-sensitizing allergens among patients with clinically suspected allergic contact dermatitis.

Authors:  Zahid Shakoor; Ahlam S Al-Mutairi; Afnan M Al-Shenaifi; Areej M Al-Abdulsalam; Bashayer Z Al-Shirah; Shahad A Al-Harbi
Journal:  Saudi Med J       Date:  2017-09       Impact factor: 1.484

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.